131 related articles for article (PubMed ID: 34116188)
1. Binding activity of Valeriana fauriei root extract on GABA
Ota M; Ni H; Maki Y; Kato D; Moriguchi S; Nakayama S; Oiwa Y; Ishiuchi K; Makino T
J Ethnopharmacol; 2021 Oct; 278():114262. PubMed ID: 34116188
[TBL] [Abstract][Full Text] [Related]
2. Prolonging effects of Valeriana fauriei root extract on pentobarbital-induced sleep in caffeine-induced insomnia model mice and the pharmacokinetics of its active ingredients under conditions of glycerol fatty acid ester as emulsifiers.
Ota M; Maki Y; Xu LY; Makino T
J Ethnopharmacol; 2022 Nov; 298():115625. PubMed ID: 35970315
[TBL] [Abstract][Full Text] [Related]
3. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid.
Trauner G; Khom S; Baburin I; Benedek B; Hering S; Kopp B
Planta Med; 2008 Jan; 74(1):19-24. PubMed ID: 18095218
[TBL] [Abstract][Full Text] [Related]
4. Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation.
Nam SM; Choi JH; Yoo DY; Kim W; Jung HY; Kim JW; Kang SY; Park J; Kim DW; Kim WJ; Yoon YS; Hwang IK
Exp Gerontol; 2013 Nov; 48(11):1369-77. PubMed ID: 24055511
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant principles of Valeriana fauriei roots.
Oshima Y; Matsuoka S; Ohizumi Y
Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):169-70. PubMed ID: 7895306
[TBL] [Abstract][Full Text] [Related]
6. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release.
Ortiz JG; Nieves-Natal J; Chavez P
Neurochem Res; 1999 Nov; 24(11):1373-8. PubMed ID: 10555777
[TBL] [Abstract][Full Text] [Related]
7. Transition of Psychotropic Drugs in Japanese Pharmacopoeia (JP) (Part 18) The Study for New Knowledge and Decisions regarding Cultivation Method for Japanese Valerian (Kisso).
Yanagisawa K
Yakushigaku Zasshi; 2016; 51(2):96-103. PubMed ID: 30183148
[TBL] [Abstract][Full Text] [Related]
8. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain.
Cavadas C; Araújo I; Cotrim MD; Amaral T; Cunha AP; Macedo T; Ribeiro CF
Arzneimittelforschung; 1995 Jul; 45(7):753-5. PubMed ID: 8573216
[TBL] [Abstract][Full Text] [Related]
9. Cell death-inducing activities via Hsp inhibition of the sesquiterpenes isolated from Valeriana fauriei.
Matsumoto T; Kitagawa T; Imahori D; Yoshikawa H; Okayama M; Kobayashi M; Kojima N; Yamashita M; Watanabe T
J Nat Med; 2021 Sep; 75(4):942-948. PubMed ID: 34212302
[TBL] [Abstract][Full Text] [Related]
10. Commercial valerian interactions with [3H]Flunitrazepam and [3H]MK-801 binding to rat synaptic membranes.
Ortiz JG; Rassi N; Maldonado PM; González-Cabrera S; Ramos I
Phytother Res; 2006 Sep; 20(9):794-8. PubMed ID: 16819753
[TBL] [Abstract][Full Text] [Related]
11. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
[TBL] [Abstract][Full Text] [Related]
12. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.
Dietz BM; Mahady GB; Pauli GF; Farnsworth NR
Brain Res Mol Brain Res; 2005 Aug; 138(2):191-7. PubMed ID: 15921820
[TBL] [Abstract][Full Text] [Related]
13.
Choi JH; Lee MJ; Chang Y; Lee S; Kim HJ; Lee SW; Kim YO; Cho IH
Rejuvenation Res; 2020 Jun; 23(3):245-255. PubMed ID: 31452446
[TBL] [Abstract][Full Text] [Related]
14. GABAA receptor subtypes: ligand binding heterogeneity demonstrated by photoaffinity labeling and autoradiography.
Bureau MH; Olsen RW
J Neurochem; 1993 Oct; 61(4):1479-91. PubMed ID: 8397295
[TBL] [Abstract][Full Text] [Related]
15. In silico screening of GABA aminotransferase inhibitors from the constituents of Valeriana officinalis by molecular docking and molecular dynamics simulation study.
Park JY; Lee Y; Lee HJ; Kwon YS; Chun W
J Mol Model; 2020 Aug; 26(9):228. PubMed ID: 32780180
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic effects of Japanese valerian root extract.
Sakamoto T; Mitani Y; Nakajima K
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):758-61. PubMed ID: 1611689
[TBL] [Abstract][Full Text] [Related]
17. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis.
Fernández S; Wasowski C; Paladini AC; Marder M
Pharmacol Biochem Behav; 2004 Feb; 77(2):399-404. PubMed ID: 14751470
[TBL] [Abstract][Full Text] [Related]
18. Telemetry as a tool to measure sedative effects of a valerian root extract and its single constituents in mice.
Chow NK; Fretz M; Hamburger M; Butterweck V
Planta Med; 2011 May; 77(8):795-803. PubMed ID: 21154200
[TBL] [Abstract][Full Text] [Related]
19. A FLIPR Assay for Discovery of GABAA Receptor Modulators of Natural Origin.
Faleschini MT; Maier A; Fankhauser S; Thasis K; Hebeisen S; Hamburger M; Butterweck V
Planta Med; 2019 Aug; 85(11-12):925-933. PubMed ID: 31127604
[TBL] [Abstract][Full Text] [Related]
20. Clathrin-coated vesicles from bovine brain contain uncoupled GABAA receptors.
Tehrani MH; Baumgartner BJ; Barnes EM
Brain Res; 1997 Nov; 776(1-2):195-203. PubMed ID: 9439813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]